title: [Clinical studies on 228 renal transplants].
abstract: We studied patient survival and graft survival rates by dividing 228 renal transplants into seven groups according to their immunosuppressive regimen and the degree of histocompatibility. Both patient survival and graft survival rates of HLA identical sibling (Id Sib), living related transplantation with cyclosporin (CYA), transplantation with donor-specific transfusion and anti-lymphocyte globulin (DST.ALG) and cadaveric transplantation with cyclosporin (CYA.Cad) groups were better than those of living related transplantation with ALG, without DST (ALG), living related transplantation with azathioprine and steroid (Non-DST.Non-ALG) and cadaveric transplantation without cyclosporin (Conv.Cad) groups. The incidence and severity of acute rejection were lower in Id Sib, CYA, DST.ALG and CYA.Cad groups than in other groups. The incidence of infections was the highest in Conv.Cad group and that of fatal infections was higher in ALG, Non-DST.Non-ALG and Conv.Cad groups than in other groups. These results indicated that acute rejection and infection were two important factor that influenced the survival rates of these patients. Up to now, the graft survival rate of CYA.Cad group has been much improved as compared to that of Conv.Cad group and was better than those of ALG and Non-DST.Non-ALG groups. The fact urges us to promote more cadaveric renal transplantation in our country by virtue of ciclosporin.
authors.affiliation: Department of Organ Transplantatin, University of Tokyo, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Sugimoto
authors.forename: N
authors.initials: N
authors.lastname: Akiyama
authors.forename: O
authors.initials: O
authors.lastname: Otsubo
authors.forename: S
authors.initials: S
authors.lastname: Tomikawa
authors.forename: K
authors.initials: K
authors.lastname: Mita
authors.forename: Y
authors.initials: Y
authors.lastname: Bekku
authors.forename: T
authors.initials: T
authors.lastname: Imai
mesh_terms: D000328:Adult; D001803:Blood Transfusion / Q000379:methods; D005260:Female; D006084:Graft Rejection; D006085:Graft Survival; D006648:Histocompatibility; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007239:Infections / Q000150:complications / Q000401:mortality; D007674:Kidney Diseases / Q000401:mortality / Q000601:surgery; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged